CHANGES IN THE MANAGEMENT OF DUCTAL CARCINOMA IN SITU BEFORE THE RELEASE OF CLINICAL PRACTICE RECOMMENDATIONS IN AUSTRALIA: THE CASE IN VICTORIA

Background:  This study examines changes in the management of ductal carcinoma in situ between 1995 and 1999 in the Australian State of Victoria. This period was before the release of Australian treatment recommendations.

[1]  T. Tuttle,et al.  Trends in the treatment of ductal carcinoma in situ of the breast. , 2004, Journal of the National Cancer Institute.

[2]  R. Mansel.  Ductal carcinoma in situ: surgery and radiotherapy. , 2003, Breast.

[3]  M. S. Hamann,et al.  Local and national trends over a decade in the surgical treatment of ductal carcinoma in situ. , 2003, American journal of surgery.

[4]  M. Silverstein,et al.  Ductal carcinoma in situ: USC/Van Nuys Prognostic Index and the impact of margin status. , 2003, Breast.

[5]  M. Silverstein.  An argument against routine use of radiotherapy for ductal carcinoma in situ. , 2003, Oncology.

[6]  J. Houghton.  Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomized controlled trial , 2003, The Lancet.

[7]  K. Mokbel.  Current management of ductal carcinoma in situ of the breast , 2003, International Journal of Clinical Oncology.

[8]  J. Collins,et al.  Surgical management of ductal carcinoma in situ in Australia in 1995 , 2002, ANZ journal of surgery.

[9]  A. Douglas-Jones,et al.  Effect of margins of excision on recurrence after local excision of ductal carcinoma in situ of the breast , 2002, Journal of clinical pathology.

[10]  C. de Wolf,et al.  Management of women with ductal carcinoma in situ of the breast: a population-based study. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  D. Dillon,et al.  Correlation of clinical and pathologic features with outcome in patients with ductal carcinoma in situ of the breast treated with breast-conserving surgery and radiotherapy. , 2001, International journal of radiation oncology, biology, physics.

[12]  N. Wolmark,et al.  Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience. , 2001, Seminars in oncology.

[13]  L Duchateau,et al.  Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  R. Cote,et al.  Ductal carcinoma in situ (DCIS) of the breast: diagnostic and therapeutic controversies1 , 2001 .

[15]  J. Cawson,et al.  Axillary dissection and ductal carcinoma in situ of the breast: a change in practice. , 2000, The Australian and New Zealand journal of surgery.

[16]  G. Schwartz,et al.  Consensus Conference on the Classification of Ductal Carcinoma of the Breast, April 22–25, 1999 , 2000 .

[17]  G. Schwartz,et al.  [The consensus conference on the treatment of in situ ductal carcinoma of the breast, April 22-25, 1999]. , 2000, Bulletin du cancer.

[18]  G. Noël,et al.  [Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from national surgical adjuvant breast and bowel project B-17]. , 1999, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[19]  J Costantino,et al.  Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight‐year update of Protocol B‐17 , 1999, Cancer.

[20]  Geoff Delaney M.B.B.S.,et al.  Predictors of local recurrence after treatment of ductal carcinoma in situ - A meta-analysis , 1999 .

[21]  J. Boyages,et al.  Ductal carcinoma in situ. Part 2: Treatment. , 1997, The Australian and New Zealand journal of surgery.

[22]  M. Lagios.  Duct carcinoma in situ: biological implications for clinical practice. , 1996, Seminars in oncology.

[23]  S. Perry.  Reports from the Australian Institute of Health and Welfare (AIHW) , 1995, International Journal of Technology Assessment in Health Care.

[24]  Joseph Costantino,et al.  Pathologic findings from the national surgical adjuvant breast project (NSABP) protocol B‐17. Intraductal carcinoma (ductal carcinoma in situ) , 1995, Cancer.

[25]  G. W. Eklund,et al.  Percutaneous large-core breast biopsy: a multi-institutional study. , 1994, Radiology.

[26]  B Fisher,et al.  Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. , 1993, The New England journal of medicine.

[27]  M. Silverstein,et al.  Axillary lymphadenectomy for intraductal carcinoma of the breast. , 1991, Surgery, gynecology & obstetrics.

[28]  M. Silverstein,et al.  Axillary lymph node dissection for intraductal breast carcinoma‐is it indicated? , 1987, Cancer.

[29]  N. Bijker,et al.  Breast-conserving therapy for ductal carcinoma in situ Bijker , 2008 .

[30]  J. Boyages,et al.  The clinical management of ductal carcinoma in situ, lobular carcinoma in situ and atypical hyperplasia of the breast , 2003 .

[31]  D. Lowther,et al.  Margin width as a determinant of local control with and without radiation therapy for ductal carcinoma in situ (DCIS) of the breast , 2001, International journal of cancer.

[32]  G. Schwartz,et al.  Consensus Conference on the Treatment of In Situ Ductal Carcinoma of the Breast, April 22-25, 1999. , 2000, Cancer.

[33]  J. Boyages,et al.  Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis. , 1999, Cancer.